Feed BRKR
BR

Bruker

BRKR · NASDAQ

$60.67 +7.12% (+$4.03)
1M +6.70%
Market Cap $9.24B
P/E Ratio -
Div. Yield 0.33%
ROE 2.92%

Bulios Fair Price

$31.32

48.4% downside

Current Price

$60.67

Undervalued Fair Value Overvalued

According to Bulios Fair Price, BRKR is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
5/9
Valuation
17 /100
Expensive
EV/EBITDA 44.27x
P/S 2.64x
P/B 3.85x
Growth
49 /100
Stable
Rev. growth 10.74%
FCF growth 33.19%
Book val. growth 30.17%
Profitability
30 /100
Weak
Gross margin 46.69%
Net margin 2.03%
Op. margin 3.61%
Quality
20 /100
Poor
ROIC 6.28%
ROE 2.92%
ROA 1.18%
Debt
34 /100
Moderate
Debt/Equity 0.80x
Current ratio 1.85x
Int. coverage 0.40x
Stability
45 /100
Moderate
Beta 1.26x
Rev. volatility 7.87%
EPS volatility 85.42%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about BRKR
Online

About the company

Bruker Corporation (BRKR) is a leading global provider of scientific and analytical instruments for research and diagnostics. The company develops and manufactures devices and technologies for various industries, including biomedicine, pharmaceuticals, materials science, and more. It is known for its innovative approaches and products that enable researchers and experts to gain deeper insights into materials and biological systems. With its research efforts, diverse portfolio, and extensive experience, investing in Bruker Corporation (BRKR) shares may present an interesting investment opportunity for investors interested in the scientific and analytical sector.

Sector

Healthcare

Industry

Medical - Devices

CEO

Frank H. Laukien

Employees

11,085

Headquarters

Billerica

Upcoming events

21 SEP

Ex-Dividend

Ex-dividend date

4d
07 OCT

Dividend Payment

Payment date

20d
02 NOV

Earnings

Upcoming earnings report

46d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.